Navigation Links
SafeWire, LLC. Announces first US product launch of Y-wire™
Date:4/9/2012

COOPER CITY, Fla., April 9, 2012 /PRNewswire-iReach/ -- SafeWire, LLC., a privately held medical company, announced today it has officially launched Y-wire™ in the United States. 

(Logo: http://photos.prnewswire.com/prnh/20120409/CG84447)

Y-wire is a guidewire that is designed to mitigate forward migration during surgery; it also helps eliminate wire kinking issues.  The product was pilot launched in 2011 and to date surgeons have utilized more than 3,500 wires.  The Y-wire is now being commercially released on a national basis.

Dr. James Billys in Tampa, FL has been utilizing the product over during the pilot launch.

"Y-wire has enhanced my ability to perform MIS procedures with cannulated pedicle screws.  I have seen a 50% reduction in fluoroscopy since switching from a standard guidewire.  I have implanted approximately 750 screws while utilizing Y-wire without any breaching of the anterior cortex.  In short, the product makes my procedures faster with less fluoroscopy and with almost no concern for wire migration." – Dr. James Billys. 

The eventual final design has incorporated increased stiffness and bone purchase over the pilot launched product. Wyatt Geist, CEO of SafeWire commented on the national US launch.  "We believe that our first product to market will help improve Minimal invasive procedures.  The feedback that we have received from surgeons in the pilot has been very positive.  It is our hope to continue to improve procedures by releasing new products that will reduce fluoroscopy, minimizing inadvertent trajectories, and will make the procedures faster and easier. The next product to be launched is scheduled in May 2012."

About SafeWire, LLC.
SafeWire, LLC is dedicated to improving MIS procedures in the orthopedic and spinal arenas. The first released product, Y-wire, addresses guidewire improvement for instruments and implants. Other MIS areas that will be addressed with product releases should happen in the next 30 to 60 days.  More information on the company can be found at www.safe-wire.com


Media Contact: Wyatt Geist SafeWire, LLC, 800-286-9155, customerservice@safe-wire.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE SafeWire, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies
2. Rapid Fire Marketing Announces the First Shipment of its Vapor Inhaler Model Named the CannaCig Has Passed All Patient Tests; Second Round of Production to Start This Week
3. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
4. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2012 Results
5. BioNeutral Group Announces Positive Results for the Ygiene 206 Sterilization Tests
6. Enanta Announces Positive Phase 2 Results From Interferon-Free Combination Studies with ABT-450 for Hepatitis C Treatment to be Presented at EASL
7. BONESUPPORTS New CEO Announces 100 Day Plan
8. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
9. Psyche Systems Announces Availability of MicroPath, the First LIS for Microbiology
10. Net Medical Xpress Announces 2011 Results
11. Weikang Bio-Technology Group Co., Inc. Announces Fiscal Year 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
Breaking Medicine Technology:
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, ... of Cisco Select certification and SMB specialization. Altura is now qualified to ... In earning the Select Certification, Altura fulfilled the training and exam requirements for ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... ... 21, 2017 , ... Contrary to popular perception, a new ... at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a ... the United States. The study, Trends in Fighting and Violence Among Adolescents ...
(Date:4/21/2017)... ... ... Brady (NYSE:BRC), a global leader in industrial and safety printing ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally recognized ... for use on chemical drums shipped by sea. , “Achieving BS5609 certification ...
Breaking Medicine News(10 mins):